CAPD, an acceptable form of therapy in elderly ESRD patients: a comparative study.

医学 腹膜透析 内科学 透析 重症监护医学 连续不卧床腹膜透析 生活质量(医疗保健)
作者
Baek My,Tae-Hwan Kwon,Kim Yl,Cho Dk
出处
期刊:Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 卷期号:13: 158-161 被引量:17
标识
摘要

Rapid growth in the number of dialysis patients over the age of 65 is occurring coincidentally with the overall aging of the general population. Elderly patients are often poor and physically incapacitated, needing family or social support. These patients may also be susceptible to malnutrition and have multiple complicating medical disorders in addition to end-stage renal disease (ESRD). Thus the selection of an appropriate dialysis modality is particularly critical in elderly patients. Continuous ambulatory peritoneal dialysis (CAPD) offers many advantages to elderly patients, including hemodynamic stability, steady-state chemistries, and no need to create a vascular access. However, little data are available in the literature documenting the use of CAPD in this setting. Therefore, to evaluate the efficacy of CAPD in elderly patients, we retrospectively reviewed the clinical outcomes of 23 patients 65 years of age or older at the start of CAPD (elderly group). Then for each of these patients, 23 comparison subjects younger than 65 were chosen from CAPD patients at our hospital (control group). The control group was matched for sex, CAPD duration, cause of ESRD, and initial connection device. In the elderly group, 23 patients (12 male, 11 female) with a mean age of 70 +/- 4 years (range 65-86 years) were treated with CAPD for 15 +/- 17 months. In the control group, 23 patients (12 male, 11 female) with a mean age of 41 +/- 11 (range 18-57) were treated with CAPD for 16 +/- 17 months. Diabetic nephropathy was the cause of ESRD in 35% of patients. The negative CAPD selection of patients was higher in the elderly group (61% vs 17%, p = 0.0025) as well as in the group that needed a helper (61% vs 17%, p = 0.0025). The exit-site infection and peritonitis rates were not statistically different between the two groups (0.43 vs 0.91 episodes/patient-year and 1.46 vs 2.03 episodes/patient-year). The dialysate leakage and bleeding rates were comparable (13% vs 22% and 9% vs 9%). One-year catheter survival was similar in the elderly and younger patients (87.5% vs 84.0%). Although the negative CAPD selection of patients was higher in the elderly group, outcomes were similar to those seen in younger patients. Therefore, CAPD is an acceptable form of therapy for the elderly ESRD patients, particularly if a helper can participate.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
韩mingyang发布了新的文献求助10
刚刚
CKK发布了新的文献求助30
1秒前
hhh完成签到 ,获得积分10
2秒前
4秒前
陌路发布了新的文献求助10
4秒前
5秒前
1111111完成签到,获得积分10
5秒前
Oasis完成签到,获得积分10
7秒前
8秒前
菜菜包发布了新的文献求助10
10秒前
淡定自中完成签到,获得积分10
10秒前
所所应助123采纳,获得10
13秒前
sxd完成签到,获得积分10
14秒前
666完成签到 ,获得积分10
14秒前
yyq完成签到 ,获得积分10
15秒前
15秒前
15秒前
鳗鱼鸽子发布了新的文献求助20
15秒前
15秒前
16秒前
Heinrich完成签到,获得积分10
16秒前
干净丑发布了新的文献求助10
17秒前
18秒前
wqw发布了新的文献求助200
19秒前
19秒前
Julio614发布了新的文献求助10
19秒前
20秒前
20秒前
跳跳完成签到,获得积分10
21秒前
21秒前
21秒前
智慧门完成签到 ,获得积分10
22秒前
22秒前
23秒前
查查文献完成签到 ,获得积分10
23秒前
xjcy应助前交叉还在采纳,获得10
24秒前
贺光萌完成签到 ,获得积分10
25秒前
跳跳发布了新的文献求助10
25秒前
25秒前
聪明机器猫完成签到,获得积分10
26秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Environmental Leverage in Times of Climate Crisis: Product Standards, Carbon Border Measures and Preferential Trade Agreements 1000
Erwählung und Berufung bei Paulus: Bedeutung, Entwicklung und Funktion einer Vorstellung in ihrem frühjüdischen und griechisch-römischen Kontext 850
Matrix Methods in Data Mining and Pattern Recognition 510
Structural Geology: A Quantitative Introduction 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7216038
求助须知:如何正确求助?哪些是违规求助? 8847772
关于积分的说明 18671587
捐赠科研通 6871847
什么是DOI,文献DOI怎么找? 3184797
关于科研通互助平台的介绍 2346511
邀请新用户注册赠送积分活动 2159167